BioLife Sciences Inc. (BLFE)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Total Assets | - | - | 72.71 Thousand | 17.00 | 1320.00 | 12.33 Thousand |
| Total Current Assets | - | - | 71.72 Thousand | 17.00 | 1320.00 | 12.33 Thousand |
| Cash And Short Term Investments | - | - | 34.74 Thousand | 17.00 | 1320.00 | 12.33 Thousand |
| Cash and Cash Equivalents | - | - | 34.74 Thousand | 17.00 | 1320.00 | 12.33 Thousand |
| Short Term Investments | - | - | - | - | - | - |
| Net Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other Current Assets | - | - | 36.98 Thousand | - | - | - |
| Total Non-Current Assets | - | - | 991.00 | - | - | - |
| Net PPE | - | - | 991.00 | - | - | - |
| Good Will And Intangible Assets | - | - | - | - | - | - |
| Good Will | - | - | - | - | - | - |
| Intangible Assets | - | - | - | - | - | - |
| Long-Term Investments | - | - | - | - | - | - |
| Tax Assets | - | - | - | - | - | - |
| Other Non Current Assets | - | - | - | - | - | - |
| Other Assets | - | - | - | - | - | - |
| Total Liabilities | - | - | 762.3 Thousand | 1171.00 | 222.18 Thousand | 195.43 Thousand |
| Total Current Liabilities | - | - | 762.3 Thousand | 1171.00 | 155.53 Thousand | 128.79 Thousand |
| Account Payables | - | - | 492.68 Thousand | - | 79.98 Thousand | - |
| Tax Payables | - | - | - | - | - | - |
| Short Term Debt | - | - | 189.58 Thousand | - | 75.55 Thousand | 74.05 Thousand |
| Deferred Revenue | - | - | - | - | - | - |
| Other Current Liabilities | - | - | 80.03 Thousand | 1171.00 | - | 54.74 Thousand |
| Total Non Current Liabilities | - | - | - | - | 66.64 Thousand | 66.64 Thousand |
| Long-Term Debt | - | - | - | - | 66.64 Thousand | 66.64 Thousand |
| Deferred Revenue Non Current | - | - | - | - | - | - |
| Deferred Tax Liabilities Non Current | - | - | - | - | - | - |
| Other Non Current Liabilities | - | - | - | - | -1.00 | - |
| Other Liabilities | - | - | - | - | 1.00 | 1.00 |
| Total Equity | - | - | -689.58 Thousand | -1154.00 | -220.86 Thousand | -183.1 Thousand |
| Stock Holders Equity | - | - | -689.58 Thousand | -1154.00 | -220.86 Thousand | -183.1 Thousand |
| Common Stock | - | - | 5486.00 | - | 348.84 Thousand | 333.84 Thousand |
| Retained Earnings | - | - | -1.26 Million | -1154.00 | -4.89 Million | -4.84 Million |
| Accumulated other comprehensive income | - | - | -35.85 Thousand | - | - | -333.84 Thousand |
| Common Stock Equity | - | - | -689.58 Thousand | -1154.00 | -220.86 Thousand | -183.1 Thousand |
| Capital Lease Obligation | - | - | - | - | - | - |
| Total Investments | - | - | - | - | - | - |
| Total Debt | - | - | 189.58 Thousand | - | 142.19 Thousand | 140.69 Thousand |
| Net Debt | - | - | 154.84 Thousand | -17.00 | 140.87 Thousand | 128.36 Thousand |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 |
|---|---|---|---|---|---|---|
| Total Assets | - | - | - | - | - | - |
| Total Current Assets | - | - | - | - | - | - |
| Cash And Short Term Investments | - | - | - | - | - | - |
| Cash and Cash Equivalents | - | - | - | - | - | - |
| Short Term Investments | - | - | - | - | - | - |
| Net Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other Current Assets | - | - | - | - | - | - |
| Total Non-Current Assets | - | - | - | - | - | - |
| Net PPE | - | - | - | - | - | - |
| Good Will And Intangible Assets | - | - | - | - | - | - |
| Good Will | - | - | - | - | - | - |
| Intangible Assets | - | - | - | - | - | - |
| Long-Term Investments | - | - | - | - | - | - |
| Tax Assets | - | - | - | - | - | - |
| Other Non Current Assets | - | - | - | - | - | - |
| Other Assets | - | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - | - |
| Total Current Liabilities | - | - | - | - | - | - |
| Account Payables | - | - | - | - | - | - |
| Tax Payables | - | - | - | - | - | - |
| Short Term Debt | - | - | - | - | - | - |
| Deferred Revenue | - | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - | - |
| Total Non Current Liabilities | - | - | - | - | - | - |
| Long-Term Debt | - | - | - | - | - | - |
| Deferred Revenue Non Current | - | - | - | - | - | - |
| Deferred Tax Liabilities Non Current | - | - | - | - | - | - |
| Other Non Current Liabilities | - | - | - | - | - | - |
| Other Liabilities | - | - | - | - | - | - |
| Total Equity | - | - | - | - | - | - |
| Stock Holders Equity | - | - | - | - | - | - |
| Common Stock | - | - | - | - | - | - |
| Retained Earnings | - | - | - | - | - | - |
| Accumulated other comprehensive income | - | - | - | - | - | - |
| Common Stock Equity | - | - | - | - | - | - |
| Capital Lease Obligation | - | - | - | - | - | - |
| Total Investments | - | - | - | - | - | - |
| Total Debt | - | - | - | - | - | - |
| Net Debt | - | - | - | - | - | - |
YAYLA
GDXRF
VINS
NAFS
600732
BKGFF